Tamiflu

Treatment of the Flu

Tamiflu is prescribed to treat symptoms caused by influenza viruses. It is approved for use in adults and children as young as 2 weeks old who have shown symptoms for no more than two days. When taken early, it can help:

• Make flu symptoms less severe.
• Shorten the time it takes to recover.
• Reduce the risk of certain complications that may require antibiotics.

Prevention of the Flu

This medication is also used to prevent the flu in adults and children 1 year of age and older. It may be prescribed if you have been in close contact with someone who has the flu or during a flu outbreak in the community.

Important Considerations

Tamiflu is specifically designed to target influenza viruses. It is not effective for treating:

• The common cold.
• Bacterial infections.
• Other types of viral infections, such as those that cause the "stomach flu."

It is important to note that Tamiflu is not a substitute for the annual flu vaccine. Health experts recommend getting a flu shot every year as the primary way to protect against the virus.

Mechanism of Action

Tamiflu belongs to a class of drugs known as neuraminidase inhibitors. It targets a specific enzyme called neuraminidase, which is found on the surface of the influenza virus. This enzyme acts like a key that allows newly formed virus particles to break out of an infected cell and move on to infect neighboring healthy cells.

By blocking this enzyme, Tamiflu effectively traps the virus inside the already infected cells. This prevents the infection from spreading further within the respiratory system, which can help shorten the duration of the illness and reduce the severity of symptoms.

Effectiveness and Timing

Tamiflu is active against both Influenza A and Influenza B viruses. Because the medication works by stopping the spread of the virus rather than killing it directly, it is most effective when taken as soon as possible after symptoms appear. Clinical evidence suggests that the treatment is most beneficial when started within 48 hours of the first signs of the flu.

Common Side Effects

The most frequently reported side effects of Tamiflu include:

• Nausea
• Vomiting
• Headache
• General pain

These symptoms often occur with the first few doses and may decrease as treatment continues. Taking the medication with food or milk can help reduce the likelihood of stomach upset.

Serious Side Effects

While uncommon, some people may experience serious side effects. Seek medical help immediately if you notice any of the following:

• Neuropsychiatric symptoms: Sudden confusion, delirium, hallucinations, or unusual behavior. These events have been reported primarily in children and adolescents with the flu.
• Severe skin reactions: A painful red or purple rash that spreads and causes blistering or peeling.
• Allergic reactions: Symptoms such as hives, swelling of the face, lips, or throat, and difficulty breathing.

Neuropsychiatric Events

There have been reports of delirium and abnormal behavior leading to self-injury or fatalities in patients with influenza who were taking Tamiflu. These events appear to occur most frequently in children and adolescents and often have an abrupt onset. Patients should be monitored closely for signs of unusual behavior, confusion, or agitation.

Serious Skin and Hypersensitivity Reactions

Rare but serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. Tamiflu should be stopped immediately if a severe rash or signs of an allergic reaction occur, such as:

• Swelling of the face or tongue
• Difficulty breathing
• Blistering or peeling skin
• Severe itching or hives

Bacterial Infections

Tamiflu is an antiviral medication and is not effective against bacterial infections. Serious bacterial complications can occur alongside or follow the flu. If symptoms worsen or new symptoms develop, further medical evaluation may be necessary to rule out bacterial pneumonia or other infections.

Vaccination Considerations

Tamiflu may interfere with the effectiveness of the live attenuated influenza vaccine (nasal spray vaccine). It is generally recommended to avoid the live vaccine for at least 48 hours after stopping Tamiflu, and to wait at least two weeks after receiving the live vaccine before starting Tamiflu, unless otherwise directed by a healthcare provider. The inactivated (injectable) flu vaccine can be administered at any time.

Contraindications

Tamiflu is contraindicated in individuals with a known serious hypersensitivity to oseltamivir phosphate or any component of the product.

Pregnancy

Pregnant individuals are at a higher risk for severe complications from the flu. While data from studies have not shown an increased risk of birth defects or other pregnancy complications associated with Tamiflu, it is typically reserved for cases where the benefit to the mother justifies the potential risk to the fetus.

Breastfeeding

Tamiflu and its active components are known to pass into breast milk in very small amounts. These levels are unlikely to cause adverse effects in a nursing infant. Decisions regarding breastfeeding while taking this medication should be made in consultation with a healthcare professional.

Important Considerations

If you are pregnant or nursing, talk to your healthcare provider about:

• The risks of untreated influenza compared to the risks of the medication.
• The timing of your symptoms and when to start treatment.
• Any concerns regarding the health of your baby.

Available Forms

Tamiflu is manufactured in oral formulations for the treatment and prevention of influenza. The available forms include:

• Capsules: Hard gelatin capsules intended for oral administration.
• Powder for Oral Suspension: A powder that is reconstituted by a pharmacist into a liquid. This form is typically used for patients who have difficulty swallowing capsules or for specific pediatric needs.

FDA Approval and Generic Availability

Tamiflu (oseltamivir phosphate) was originally approved by the U.S. Food and Drug Administration (FDA) in 1999. In 2016, the FDA approved the first generic version of the medication, which increased the availability of oseltamivir in capsule and oral suspension forms.

Approved Indications

The FDA has authorized Tamiflu for the following specific uses:

• Treatment: For patients 2 weeks of age and older who have experienced flu symptoms for no more than 48 hours.
• Prevention: For patients 1 year of age and older to prevent the flu after exposure to an infected individual or during a community outbreak.

Regulatory Safety Monitoring

The FDA has issued safety communications regarding neuropsychiatric events associated with Tamiflu use, particularly in children and adolescents. These events may include symptoms such as delirium, hallucinations, confusion, and self-injury. While it is not certain if these behaviors are caused by the medication or the influenza virus itself, the FDA requires that the product labeling include information about these potential risks. Caregivers and patients are advised to monitor for any signs of unusual behavior and contact a healthcare provider if they occur.

Generic vs. Brand Name

Tamiflu is available as a generic medication known as oseltamivir. Generic versions are typically less expensive than the brand-name drug. Both versions require a prescription from a healthcare provider.

Insurance Coverage

Most private insurance plans and Medicare Part D cover oseltamivir. The specific out-of-pocket cost or copay depends on your individual plan's formulary and deductible status. Some plans may require you to use the generic version instead of the brand name.

Other Cost Factors

• Formulation: The price can differ between the oral capsules and the liquid suspension form.
• Pharmacy Pricing: Retail prices for the medication can vary between different pharmacies.
• Assistance Programs: Some patients may be eligible for manufacturer coupons or patient assistance programs to help reduce the cost of the brand-name medication.